AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 19621678 — intervention group
Group type: COMPARATOR
Intervention: Five Bethesda markers
Number of subjects: 1531
Study 19621678 — intervention group
Group type: EXPERIMENTAL
Intervention: Two mononucleotide markers
Number of subjects: 1531
Study 16704591 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical cricothyroidotomy with a 6.0‐mm cuffed Portex tracheostomy tube
Number of subjects: 27
Study 16704591 — intervention group
Group type: COMPARATOR
Intervention: Wire-guided cricothyroidotomy using a 5.0‐mm cuffed Melker tube
Number of subjects: 27
Study 16704591 — intervention group
Group type: COMPARATOR
Intervention: Wire-guided cricothyroidotomy using a 6.0‐mm uncuffed Melker tube
Number of subjects: 27
Study 16704591 — intervention group
Group type: EXPERIMENTAL
Intervention: Cuffed tubes (Portex and cuffed Melker)
Number of subjects: 27
Study 16704591 — intervention group
Group type: COMPARATOR
Intervention: Uncuffed Melker tube
Number of subjects: 27
Study 15579778 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (0.5 mg/kg.d)
Number of subjects: 6
Study 11171785 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering therapy
Number of subjects: 49
Study 9170767 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-statement questionnaire approach
Number of subjects: 0
Study 9170767 — intervention group
Group type: COMPARATOR
Intervention: Thought-listing procedure
Number of subjects: 0
Study 8431411 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic surgery followed by post-operative physical therapy (n = 9)
Number of subjects: 21
Study 8431411 — intervention group
Group type: COMPARATOR
Intervention: Non-surgical treatment (n = 12)
Number of subjects: 21
Study 3608730 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide (16 mg per os)
Number of subjects: 9
Study 3608730 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 3608730 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide (16 mg per os) followed by naloxone (16 mg)
Number of subjects: 9
Study 3608730 — intervention group
Group type: EXPERIMENTAL
Intervention: Loperamide (16 mg per os) followed by naloxone (32 mg)
Number of subjects: 9
Study 30929605 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-medicated milk replacer (NMR) with sodium butyrate and Bacillus amyloliquefaciens
Number of subjects: 18
Study 30929605 — intervention group
Group type: COMPARATOR
Intervention: Pasteurized waste milk (PWM)
Number of subjects: 18
Study 29310611 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaliplatin + S-1 (oxaliplatin dose of 130 mg/m2)
Number of subjects: 70
Study 27608624 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based self-management training and coaching program (12 weeks, delivered by telephone)
Number of subjects: 100
Study 27608624 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 100
Study 25622286 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive stereotype activation
Number of subjects: 116
Study 25622286 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 116
Study 23265410 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased water and fruit juice consumption during the intervention period.
Number of subjects: 70
Study 23265410 — intervention group
Group type: COMPARATOR
Intervention: Increased solid fruit consumption during the control period.
Number of subjects: 70
Study 21129714 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol (1.25 mg once daily)
Number of subjects: 320
Study 21129714 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol (3.125 mg twice daily)
Number of subjects: 320
Study 21129714 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol
Number of subjects: 320
Study 21129714 — intervention group
Group type: COMPARATOR
Intervention: Carvedilol
Number of subjects: 320
Study 18353086 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface preparation (gentle curettage or abrasion with a spatula)
Number of subjects: 16
Study 18353086 — intervention group
Group type: COMPARATOR
Intervention: No surface preparation
Number of subjects: 16
Study 18353086 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 16
Study 16819684 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist-bridging external fixation
Number of subjects: 38
Study 16819684 — intervention group
Group type: COMPARATOR
Intervention: Non-bridging external fixation
Number of subjects: 38
Study 12859442 — intervention group
Group type: EXPERIMENTAL
Intervention: Butterbur (BB) 50 mg twice daily
Number of subjects: 20
Study 12859442 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 20
Study 10394525 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychotherapeutic counseling (PSITCO)
Number of subjects: 1156
Study 10394525 — intervention group
Group type: COMPARATOR
Intervention: No psychotherapeutic counseling (PSITCO)
Number of subjects: 1156
Study 9157078 — intervention group
Group type: EXPERIMENTAL
Intervention: amonafide
Number of subjects: 48
Study 9157078 — intervention group
Group type: EXPERIMENTAL
Intervention: caracemide
Number of subjects: 48
Study 9157078 — intervention group
Group type: EXPERIMENTAL
Intervention: homoharringtonine
Number of subjects: 48
Study 1812440 — intervention group
Group type: EXPERIMENTAL
Intervention: Norwegian meningococcus B vaccine
Number of subjects: 877
Study 1812440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 877
Study 6822175 — intervention group
Group type: EXPERIMENTAL
Intervention: Protective colostomy
Number of subjects: 50
Study 6822175 — intervention group
Group type: COMPARATOR
Intervention: Noncolostomy (control group)
Number of subjects: 50
Study 6822175 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 31781759 — intervention group
Group type: EXPERIMENTAL
Intervention: Same-day ART (SD ART)
Number of subjects: 274
Study 31781759 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 274
Study 30178473 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 194
Study 30178473 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamotrigine
Number of subjects: 194
Study 30178473 — intervention group
Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 194
Study 30178473 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin treatment
Number of subjects: 194
Study 26731173 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapist-guided internet-delivered acceptance-based behaviour therapy
Number of subjects: 103
Study 26731173 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control condition
Number of subjects: 103
Study 24875748 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex intervention to support recovery of service users with psychosis
Number of subjects: 28
Study 22933797 — intervention group
Group type: EXPERIMENTAL
Intervention: Cued recall tested in session 2
Number of subjects: 0
Study 22933797 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG analysis during cued recall in session 2
Number of subjects: 0
Study 22933797 — intervention group
Group type: EXPERIMENTAL
Intervention: EEG analysis after 700 ms
Number of subjects: 0
Study 20505127 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-pulse stimulation using 120% active motor threshold (AMT) conditioning stimulus (CS)
Number of subjects: 0
Study 20505127 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-pulse stimulation with varying intensities of CS (80-120% AMT) and S2 (120 and 140% AMT)
Number of subjects: 0
Study 20505127 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired-pulse paradigm with CS and S1 followed by S2
Number of subjects: 0
Study 18568789 — intervention group
Group type: EXPERIMENTAL
Intervention: Dang Gui Buxue Tang
Number of subjects: 50
Study 18568789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 15747200 — intervention group
Group type: EXPERIMENTAL
Intervention: Schizophrenic persons
Number of subjects: 581
Study 15747200 — intervention group
Group type: COMPARATOR
Intervention: Mentally healthy persons
Number of subjects: 581
Study 11922259 — intervention group
Group type: EXPERIMENTAL
Intervention: Estrogen replacement therapy
Number of subjects: 135
Study 9849707 — intervention group
Group type: EXPERIMENTAL
Intervention: Amplitude‐dependent speed of sound (SoS) measurements using DBM Sonic 1200 equipment
Number of subjects: 91
Study 9849707 — intervention group
Group type: EXPERIMENTAL
Intervention: SoS measurements combined with hip BMD
Number of subjects: 91
Study 9849707 — intervention group
Group type: COMPARATOR
Intervention: Hip BMD measurements
Number of subjects: 91
Study 8085467 — intervention group
Group type: EXPERIMENTAL
Intervention: Paroxetine
Number of subjects: 57
Study 8085467 — intervention group
Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 57
Study 2529892 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg b.d.
Number of subjects: 108
Study 2529892 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproterone acetate 100 mg t.d.s.
Number of subjects: 108
Study 2529892 — intervention group
Group type: COMPARATOR
Intervention: No active treatment (Control)
Number of subjects: 108
Study 4692674 — intervention group
Group type: EXPERIMENTAL
Intervention: Hibiscrub (4% chlorhexidine detergent solution)
Number of subjects: 0
Study 4692674 — intervention group
Group type: COMPARATOR
Intervention: Dermofax (0.75% chlorhexidine detergent solution)
Number of subjects: 0
Study 4692674 — intervention group
Group type: COMPARATOR
Intervention: Disadine scrub (povidone iodine detergent preparation)
Number of subjects: 0
Study 4692674 — intervention group
Group type: EXPERIMENTAL
Intervention: Hibiscrub (4% chlorhexidine detergent solution) after six applications
Number of subjects: 0
Study 4692674 — intervention group
Group type: COMPARATOR
Intervention: Povidone iodine after six applications
Number of subjects: 0
Study 4692674 — intervention group
Group type: COMPARATOR
Intervention: Dermofax (0.75% chlorhexidine detergent solution) after six applications
Number of subjects: 0
Study 4692674 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% chlorhexidine digluconate in 70% ethanol (second phase of disinfection)
Number of subjects: 0
Study 4692674 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% aqueous povidone iodine compresses
Number of subjects: 0
Study 4692674 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% aqueous chlorhexidine digluconate compresses
Number of subjects: 0
Study 4692674 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorocresol (0.3%) liquid soap after one application
Number of subjects: 0
Study 4692674 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorocresol (0.3%) liquid soap after six applications
Number of subjects: 0
Study 4692674 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcoholic cetrimide
Number of subjects: 0
Study 4692674 — intervention group
Group type: COMPARATOR
Intervention: 70% ethyl alcohol
Number of subjects: 0
Study 30391877 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-cephalic transcranial Direct Current Stimulation (tDCS) with anode on PPC and cathode on Cerebellum
Number of subjects: 0
Study 30391877 — intervention group
Group type: EXPERIMENTAL
Intervention: Bi-cephalic transcranial Direct Current Stimulation (tDCS) with cathode on PPC and anode on Cerebellum
Number of subjects: 0
Study 30391877 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 0
Study 30391877 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0
Study 27354031 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing cable training (SC, n = 12)
Number of subjects: 29
Study 27354031 — intervention group
Group type: COMPARATOR
Intervention: Seated machine training (SM, n = 10)
Number of subjects: 29
Study 27354031 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 29
Study 24698702 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet-wrap treatment (WWT) with diluted corticosteroids (1:3 mometasone furoate 0.1% ointment and for the face 1:19 mometasone furoate 0.1% ointment under a mask)
Number of subjects: 0
Study 24698702 — intervention group
Group type: COMPARATOR
Intervention: Emollient (petrolatum 20% in cetomacrogol cream)
Number of subjects: 0
Study 24698702 — intervention group
Group type: EXPERIMENTAL
Intervention: Wet-wrap treatment (WWT) with diluted corticosteroids
Number of subjects: 0
Study 23588625 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Cat intervention
Number of subjects: 267
Study 20716244 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant ibuprofen and paracetamol
Number of subjects: 1200000
Study 20716244 — intervention group
Group type: COMPARATOR
Intervention: Ibuprofen alone
Number of subjects: 1200000
Study 20716244 — intervention group
Group type: COMPARATOR
Intervention: Paracetamol alone
Number of subjects: 1200000
Study 18069745 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy added to locoregional treatment
Number of subjects: 0
Study 18069745 — intervention group
Group type: COMPARATOR
Intervention: Randomized trials in patients with head and neck cancers
Number of subjects: 0
Study 16360564 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic survey (tablet)
Number of subjects: 160
Study 16360564 — intervention group
Group type: COMPARATOR
Intervention: Paper survey
Number of subjects: 160
Study 16360564 — intervention group
Group type: COMPARATOR
Intervention: Comparison of missing data
Number of subjects: 160
Study 12846755 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF-1 (100 mg/kg subcutaneously twice a day for 6 days)
Number of subjects: 43
Study 12846755 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 12846755 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIGF-1
Number of subjects: 43
Study 11158455 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholesterol-lowering dietary intervention promoting adherence to a diet with 28% of energy from total fat, <8% from saturated fat, up to 9% from polyunsaturated fat, and <75 mg/1000 kcal cholesterol per day
Number of subjects: 663
Study 11158455 — intervention group
Group type: COMPARATOR
Intervention: Usual care group
Number of subjects: 663
Study 9047258 — intervention group
Group type: EXPERIMENTAL
Intervention: High dose chemotherapy followed by infusion of autologous hematopoietic stem cells and growth factors
Number of subjects: 0
Study 9047258 — intervention group
Group type: COMPARATOR
Intervention: Standard adjuvant therapies
Number of subjects: 0
Study 7962883 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecure case managers
Number of subjects: 27
Study 7962883 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoccupied case managers
Number of subjects: 27
Study 7962883 — intervention group
Group type: COMPARATOR
Intervention: Secure case managers
Number of subjects: 27
Study 3036259 — intervention group
Group type: EXPERIMENTAL
Intervention: Clomipramine (CMI)
Number of subjects: 0
Study 3036259 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine (DMI)
Number of subjects: 0
Study 3036259 — intervention group
Group type: COMPARATOR
Intervention: m-chlorophenylpiperazine (m-CPP) 0.5 mg/kg
Number of subjects: 0
Study 3036259 — intervention group
Group type: EXPERIMENTAL
Intervention: Metergoline 4 mg
Number of subjects: 0
Study 2102029 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg allopurinol + 20 mg benzbromarone
Number of subjects: 60
Study 2102029 — intervention group
Group type: COMPARATOR
Intervention: 300 mg allopurinol only
Number of subjects: 60
Study 939029 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure measurement using mercury sphygmomanometers and Physiometrics automatic recorders.
Number of subjects: 3524
Study 939029 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure measurement in black children.
Number of subjects: 3524
Study 939029 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure measurement in children in the upper five percent of pressure ranks.
Number of subjects: 3524
Study 939029 — intervention group
Group type: EXPERIMENTAL
Intervention: Stepwise multiple regression analysis of blood pressure determinants.
Number of subjects: 3524
Study 31206593 — intervention group
Group type: EXPERIMENTAL
Intervention: MSB11022
Number of subjects: 443
Study 31206593 — intervention group
Group type: COMPARATOR
Intervention: Reference adalimumab
Number of subjects: 443
Study 31206593 — intervention group
Group type: EXPERIMENTAL
Intervention: MSB11022 after switch from reference adalimumab
Number of subjects: 443
Study 31206593 — intervention group
Group type: COMPARATOR
Intervention: Reference adalimumab after switch to MSB11022
Number of subjects: 443
Study 28898714 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued care (CC) with weekly to monthly phone calls from a diabetes specialist nurse practitioner
Number of subjects: 151
Study 28898714 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) with follow-up by diabetes care providers
Number of subjects: 151
Study 28898714 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued care (CC) for insulin-treated patients
Number of subjects: 151
Study 28898714 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) for insulin-treated patients
Number of subjects: 151
Study 25728015 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived control
Number of subjects: 82
Study 25728015 — intervention group
Group type: COMPARATOR
Intervention: No perceived control
Number of subjects: 82
Study 23426413 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisture subscale of the Braden Scale
Number of subjects: 0
Study 23426413 — intervention group
Group type: EXPERIMENTAL
Intervention: Moisture subscale score groups
Number of subjects: 0
Study 20673553 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertindole
Number of subjects: 321
Study 20673553 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 321
Study 19070761 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopically assisted open reduction and internal fixation
Number of subjects: 74
Study 19070761 — intervention group
Group type: COMPARATOR
Intervention: Nonendoscopic open reduction and internal fixation using an extraoral approach
Number of subjects: 74
Study 17432641 — intervention group
Group type: EXPERIMENTAL
Intervention: Yang's cotton moxibustion
Number of subjects: 60
Study 17432641 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone and urea cream
Number of subjects: 60
Study 15333607 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol 200 microg inserted into the posterior fornix of the vagina (Group A, n=72)
Number of subjects: 144
Study 15333607 — intervention group
Group type: COMPARATOR
Intervention: Laminaria tents inserted intracervically (Group B, n=72)
Number of subjects: 144
Study 11448407 — intervention group
Group type: EXPERIMENTAL
Intervention: PTCA
Number of subjects: 891
Study 9972900 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth factor FGF injected into the myocardium during aortocoronary bypass surgery.
Number of subjects: 40
Study 9972900 — intervention group
Group type: COMPARATOR
Intervention: Control group (no FGF injection).
Number of subjects: 40
Study 7919075 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-administered health checks
Number of subjects: 8100
Study 3236382 — intervention group
Group type: EXPERIMENTAL
Intervention: Dog petting
Number of subjects: 60
Study 3236382 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking to the dog
Number of subjects: 60
Study 3236382 — intervention group
Group type: COMPARATOR
Intervention: Talking to the experimenter
Number of subjects: 60
Study 3236382 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking to or touching the dog
Number of subjects: 60
Study 3236382 — intervention group
Group type: EXPERIMENTAL
Intervention: Touching and talking to the dog
Number of subjects: 60
Study 29642075 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical sucralfate gel
Number of subjects: 40
Study 29642075 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 28532499 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic mini gastric bypass (LMGB)
Number of subjects: 80
Study 28532499 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic Roux-en-Y gastric bypass (LRYGB)
Number of subjects: 80
Study 25178692 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous amiodarone (300 mg loading dose followed by 15 mg/kg infusion for two days)
Number of subjects: 0
Study 25178692 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 23565591 — intervention group
Group type: COMPARATOR
Intervention: Intensive advice to withdraw overused medication (Group A)
Number of subjects: 137
Study 23565591 — intervention group
Group type: COMPARATOR
Intervention: Standard outpatient detoxification programme (Group B)
Number of subjects: 137
Study 23565591 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard inpatient withdrawal programme (Group C)
Number of subjects: 137
Study 21144093 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention group (dietary and exercise programmes)
Number of subjects: 104
Study 21144093 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 104
Study 21144093 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight loss intervention group
Number of subjects: 104
Study 21144093 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 104
Study 18479317 — intervention group
Group type: EXPERIMENTAL
Intervention: Various interventions for depression, schizophrenia, and bipolar disorder; specific interventions and dosages not provided.
Number of subjects: 0
Study 17209345 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 24
Study 17209345 — intervention group
Group type: COMPARATOR
Intervention: No erythromycin (Control)
Number of subjects: 24
Study 12538778 — intervention group
Group type: EXPERIMENTAL
Intervention: Former IDA children
Number of subjects: 0
Study 12538778 — intervention group
Group type: COMPARATOR
Intervention: Nonanemic children
Number of subjects: 0
Study 10743865 — intervention group
Group type: EXPERIMENTAL
Intervention: 25% metronidazole gel
Number of subjects: 43
Study 10743865 — intervention group
Group type: COMPARATOR
Intervention: No gel (control)
Number of subjects: 43
Study 8752181 — intervention group
Group type: EXPERIMENTAL
Intervention: Scoring system using ST-segment and T-wave changes on ECG (variables: ST-segment elevation in leads V1 to V4 and T-wave negativity in leads I, aVL, and V5)
Number of subjects: 451
Study 1460163 — intervention group
Group type: EXPERIMENTAL
Intervention: D-fenfluramine
Number of subjects: 21